Seattle Genetics, Daiichi Sankyo strike licensing deal

07/9/2008 | SeattlePI.com

Seattle Genetics has entered into a licensing agreement with Daiichi Sankyo Co. Ltd. for its "antibody drug conjugate" technology. The deal entitles the biotech firm to an upfront payment of $4 million and allows the Japanese drugmaker to use the technique to target an antigen found on various forms of solid tumors.

View Full Article in:

SeattlePI.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations